Exhibitor Product Theater - A Treatment Option That Can Be Used Before Biologics For Your Moderate UC Patients

Michael V. Chiorean, MD, FACG

This event is sponsored by Bristol Myers Squibb, and the speaker is a paid consultant of Bristol Myers Squibb. The information contained in this product theater does not necessarily reflect the content of the approved Canadian product monograph. Only open to U.S. HCPs and AHCPs. Not intended for Canadian Audience.

Please join Bristol Myers Squibb for a conversation on A Treatment Option That Can Be Used Before Biologics For Your Moderate UC Patients. The presentation will include an overview of a treatment option for ulcerative colitis and key efficacy and safety data from a phase 3 clinical trial and ongoing open-label extension trial.

Open to all in-person ACG 2023 attendees, industry-sponsored product theater events provide additional educational opportunities. These programs are independent of the ACG 2023 Annual Scientific Meeting and Postgraduate Course programs. No CME is provided for Exhibitor Product Theater presentations.